Bernard A, Foult J M, Lefévre T, Ricolfi F
J Radiol. 1987 May;68(5):353-60.
The coronarographic risk is 3 deaths per thousand and 2 non-fatal complications per cent. Fatal cases are always related to severe coronary lesions, particularly stenosis of main trunk. Their incidence is equivalent during catheterization by the humeral or femoral routes whereas local complications are more frequent by the humeral approach. In the series of 2,300 successive coronarography examinations reported there were less than 4 deaths per thousand and 1.82 complications per cent. Four factors contribute to the reduction in high risk coronarography mortality when the following protocol is used. First, routine coronary opacification at start of investigations after determination of left ventricular pressures allowing, in patients with very severe coronary lesions and/or markedly altered left ventricular function, the ventriculography to be postponed until the following day or even cancelled. Second, use of a new contrast medium of lower osmolarity possessing advantages over older products. Third, and principally, institution of a very strict pre- and per-coronarography drug protocol, controlled use of an intraaortic diastolic counter-current balloon, and notably placed in position during examination in patients with very pronounced stenosis of main trunk. In these cases the arterial desilet is left in place for 24 hours after examination to delay vagal reflex provoked by compression and to allow urgent insertion if necessary of an intra-aortic diastolic counter-current balloon catheter. Fourth, use of Diltiazem intracoronary in case of major spasm and Streptokinase and possible metallic guide to obtain repermeability of a thrombosis.(ABSTRACT TRUNCATED AT 250 WORDS)
冠状动脉造影的风险为每千例中有3例死亡,每百例中有2例非致命并发症。致命病例总是与严重的冠状动脉病变有关,特别是主干狭窄。在经肱动脉或股动脉途径进行导管插入术时,其发生率相当,而局部并发症在经肱动脉途径时更为常见。在报告的连续2300例冠状动脉造影检查系列中,每千例死亡少于4例,每百例并发症为1.82例。当采用以下方案时,有四个因素有助于降低高风险冠状动脉造影的死亡率。首先,在测定左心室压力后开始检查时进行常规冠状动脉显影,对于冠状动脉病变非常严重和/或左心室功能明显改变的患者,可将心室造影推迟至次日,甚至取消。其次,使用一种新的低渗造影剂,其比旧产品具有优势。第三,也是主要的,制定非常严格的冠状动脉造影前和造影时的药物方案,控制使用主动脉内舒张期逆流球囊,特别是在主干明显狭窄的患者检查时放置到位。在这些情况下,检查后将动脉鞘管留置24小时,以延迟压迫引起的迷走反射,并在必要时允许紧急插入主动脉内舒张期逆流球囊导管。第四,在发生严重痉挛时冠状动脉内使用地尔硫䓬,以及使用链激酶和可能的金属导丝以实现血栓再通。(摘要截短至250字)